308 related articles for article (PubMed ID: 30594067)
1. DNA damage checkpoint response to aflatoxin B1.
Engin AB; Engin A
Environ Toxicol Pharmacol; 2019 Jan; 65():90-96. PubMed ID: 30594067
[TBL] [Abstract][Full Text] [Related]
2. Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
[TBL] [Abstract][Full Text] [Related]
3. DNA polymerase ζ limits chromosomal damage and promotes cell survival following aflatoxin exposure.
Lin YC; Owen N; Minko IG; Lange SS; Tomida J; Li L; Stone MP; Wood RD; McCullough AK; Lloyd RS
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13774-13779. PubMed ID: 27849610
[TBL] [Abstract][Full Text] [Related]
4. Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua.
Lin YC; Li L; Makarova AV; Burgers PM; Stone MP; Lloyd RS
J Biol Chem; 2014 Jun; 289(26):18497-506. PubMed ID: 24838242
[TBL] [Abstract][Full Text] [Related]
5. AFB1 hepatocarcinogenesis is via lipid peroxidation that inhibits DNA repair, sensitizes mutation susceptibility and induces aldehyde-DNA adducts at p53 mutational hotspot codon 249.
Weng MW; Lee HW; Choi B; Wang HT; Hu Y; Mehta M; Desai D; Amin S; Zheng Y; Tang MS
Oncotarget; 2017 Mar; 8(11):18213-18226. PubMed ID: 28212554
[TBL] [Abstract][Full Text] [Related]
6. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
[TBL] [Abstract][Full Text] [Related]
7. Quantitation and mapping of aflatoxin B1-induced DNA damage in genomic DNA using aflatoxin B1-8,9-epoxide and microsomal activation systems.
Denissenko MF; Cahill J; Koudriakova TB; Gerber N; Pfeifer GP
Mutat Res; 1999 Apr; 425(2):205-11. PubMed ID: 10216213
[TBL] [Abstract][Full Text] [Related]
8. An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot.
Kobertz WR; Wang D; Wogan GN; Essigmann JM
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9579-84. PubMed ID: 9275165
[TBL] [Abstract][Full Text] [Related]
9. Genome Profiling for Aflatoxin B
St John N; Freedland J; Baldino H; Doyle F; Cera C; Begley T; Fasullo M
G3 (Bethesda); 2020 Nov; 10(11):3929-3947. PubMed ID: 32994210
[TBL] [Abstract][Full Text] [Related]
10. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in DNA repair genes XRCC4 and XRCC5 and aflatoxin B1-related hepatocellular carcinoma.
Long XD; Zhao D; Wang C; Huang XY; Yao JG; Ma Y; Wei ZH; Liu M; Zeng LX; Mo XQ; Zhang JJ; Xue F; Zhai B; Xia Q
Epidemiology; 2013 Sep; 24(5):671-81. PubMed ID: 23788213
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
Shen HM; Ong CN
Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
[TBL] [Abstract][Full Text] [Related]
13. Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines.
Macé K; Aguilar F; Wang JS; Vautravers P; Gómez-Lechón M; Gonzalez FJ; Groopman J; Harris CC; Pfeifer AM
Carcinogenesis; 1997 Jul; 18(7):1291-7. PubMed ID: 9230270
[TBL] [Abstract][Full Text] [Related]
14. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish.
Bailey GS; Williams DE; Wilcox JS; Loveland PM; Coulombe RA; Hendricks JD
Carcinogenesis; 1988 Nov; 9(11):1919-26. PubMed ID: 3141073
[TBL] [Abstract][Full Text] [Related]
15. Food restriction reduces aflatoxin B1 (AFB1)-DNA adduct formation, AFB1-glutathione conjugation, and DNA damage in AFB1-treated male F344 rats and B6C3F1 mice.
Chou MW; Chen W
J Nutr; 1997 Feb; 127(2):210-7. PubMed ID: 9039820
[TBL] [Abstract][Full Text] [Related]
16. Direct synthesis of aflatoxin B1-N7 guanine adduct: a reference standard for biological monitoring of dietary aflatoxin exposure in molecular epidemiological studies.
Vidyasagar T; Sujatha N; Sashidhar RB
Food Addit Contam; 1997 Jul; 14(5):457-67. PubMed ID: 9328530
[TBL] [Abstract][Full Text] [Related]
17. Low-dose microcystin-LR antagonizes aflatoxin B1 induced hepatocarcinogenesis through decreasing cytochrome P450 1A2 expression and aflatoxin B1-DNA adduct generation.
Wang L; He L; Zeng H; Fu W; Wang J; Tan Y; Zheng C; Qiu Z; Luo J; Lv C; Huang Y; Shu W
Chemosphere; 2020 Jun; 248():126036. PubMed ID: 32045972
[TBL] [Abstract][Full Text] [Related]
18. Interaction of DNA repair gene polymorphisms and aflatoxin B1 in the risk of hepatocellular carcinoma.
Yao JG; Huang XY; Long XD
Int J Clin Exp Pathol; 2014; 7(9):6231-44. PubMed ID: 25337275
[TBL] [Abstract][Full Text] [Related]
19. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
20. Low hepatic glutathione S-transferase and increased hepatic DNA adduction contribute to increased tumorigenicity of aflatoxin B1 in newborn and partially hepatectomized mice.
Shupe T; Sell S
Toxicol Lett; 2004 Mar; 148(1-2):1-9. PubMed ID: 15019083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
